Liam Kaufman currently leads product at Cambridge Cognition, a company that specializes in computerized cognitive assessments and speech-based biomarkers. From time to time Liam writes about AI, medicine and product. The intention of this site is to help him learn about these topics through writing.
Prior to Cambridge Cognition, Liam was the cofounder and CEO of Winterlight Labs. Winterlight developed speech-based biomarkers which were used by multiple biotech and life science companies to measure response to treatment and change overtime across neurology and psychiatry. Winterlight was venture backed and sold to Cambridge Cognition in January 2023.